(Q40892792)

24 September 2017

Effectiveness of early switch from intravenous to oral antibiotics in severe community acquired pneumonia: multicentre randomised trial (English)

1 reference

multicenter clinical trial

24 September 2017

0 references

0 references

0 references

2

Marc J M Bonten

1 reference

24 September 2017

Jan Jelrik Oosterheert

1

1 reference

24 September 2017

Margriet M E Schneider

3

1 reference

24 September 2017

Erik Buskens

4

1 reference

24 September 2017

Jan-Willem J Lammers

5

1 reference

24 September 2017

Willem M N Hustinx

6

1 reference

24 September 2017

Mark H H Kramer

7

1 reference

24 September 2017

Jan M Prins

8

1 reference

24 September 2017

Peter H Th J Slee

9

1 reference

24 September 2017

Karin Kaasjager

10

1 reference

24 September 2017

Andy I M Hoepelman

11

1 reference

24 September 2017

language of work or name

English

0 references

publication date

7 November 2006

1 reference

24 September 2017

1 reference

24 September 2017

333

1 reference

24 September 2017

7580

1 reference

24 September 2017

1193

1 reference

Evaluation of an algorithm for switching from IV to PO therapy in clinical practice in patients with community-acquired pneumonia

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Achieving a safe and early discharge for patients with community-acquired pneumonia

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

A controlled trial of a critical pathway for treatment of community-acquired pneumonia. CAPITAL Study Investigators. Community-Acquired Pneumonia Intervention Trial Assessing Levofloxacin

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Incidence of community-acquired pneumonia requiring hospitalization. Results of a population-based active surveillance Study in Ohio. The Community-Based Pneumonia Incidence Study Group

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Community-acquired pneumonia: the annual cost to the National Health Service in the UK.

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

A prediction rule to identify low-risk patients with community-acquired pneumonia

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Serological diagnosis of Mycoplasma pneumoniae infections: a critical review of current procedures

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Early switch from intravenous to oral cephalosporins in the treatment of hospitalized patients with community-acquired pneumonia

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Evaluation of a pneumonia practice guideline in an interventional trial

24 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Evaluation of new anti-infective drugs for the treatment of respiratory tract infections. Infectious Diseases Society of America and the Food and Drug Administration

25 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Instability on hospital discharge and the risk of adverse outcomes in patients with pneumonia

15 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Early switch from intravenous to oral antibiotics in hospitalized patients with bacteremic community-acquired Streptococcus pneumoniae pneumonia

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

A prospective, multicenter study of a pneumonia practice guideline.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Optimization of the antibiotics policy in the Netherlands. II. SWAB guidelines for the antimicrobial therapy of pneumonia in patients at home and as nosocomial infections. The Netherlands Antibiotic Policy Foundation

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Trends in infectious diseases mortality in the United States.

19 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1693658

Early Switch From Intravenous to Oral Antibiotics and Early Hospital Discharge

19 August 2018

1 reference

12 December 2020

Efficacy and safety of oral and early-switch therapy for community-acquired pneumonia: a randomized controlled trial

1 reference

12 December 2020

A prospective randomized study of inpatient iv. antibiotics for community-acquired pneumonia. The optimal duration of therapy

1 reference

12 December 2020

1 reference

12 December 2020

Early transition to oral antibiotic therapy for community-acquired pneumonia: duration of therapy, clinical outcomes, and cost analysis

1 reference

12 December 2020

10.1136/BMJ.38993.560984.BE

Identifiers

DOI

1 reference

24 September 2017

1 reference

24 September 2017

PubMed publication ID

17090560

1 reference